SeqLL Inc
OTC:ATLN
SeqLL Inc
OTC:ATLN
Price:
4.18
USD
5.03%
Market Closed
Market Cap:
$244.7m
Relative Value
The Relative Value of one
ATLN
stock under the Base Case scenario is
10.53
USD.
Compared to the current market price of 4.18 USD,
SeqLL Inc
is
Undervalued by 60%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ATLN
Relative Value
Base Case
10.53
USD
Undervaluation 60%
Multiples Across Competitors
ATLN Competitors Multiples
SeqLL Inc Competitors
SeqLL Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
SeqLL Inc
OTC:ATLN
|
232.9m USD | 0.5 | -2.3 | -11 | -9.4 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
949.8B USD | 332.5 | 3 937.7 | 1 128.4 | 2 172.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
174.7B USD | 3.9 | 26.1 | 18.4 | 24.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
132.4B USD | 5.4 | 36.6 | 18.7 | 27.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.2B CHF | 5.1 | 35 | 26.1 | 26.1 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
262.9B CNY | 5.9 | 17.4 | 17.4 | 17.4 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.5B USD | 4.5 | 24.5 | 19.2 | 23 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.9B USD | 1.7 | 20.6 | 11.6 | 17.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
28.1B USD | 8.9 | 43.7 | 28.2 | 35.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
23.9B USD | 5.9 | 27.5 | 20.5 | 22.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
